Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof

A cerebrovascular disease and ischemic technology, applied in the field of traditional Chinese medicine composition for the treatment of ischemic cerebrovascular disease, can solve the problems of high drug prices, lack of effective drugs for cerebral ischemia or cerebral infarction, etc.

Active Publication Date: 2015-06-03
启东市丰武农副产品专业合作社
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Aiming at the lack of effective drugs for the treatment of cerebral ischemia or cerebral infarction in current medical practice and the high price of the existing technology, the present invention provides a drug capable of preventing or treating cerebral ischemia or cerebral infarction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof
  • Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof
  • Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1 Chinese medicine composition mixture of the present invention

[0033] Prescription: 15 parts of Scutellaria baicalensis, 6 parts of honeysuckle, 10 parts of pomegranate peel, 10 parts of radix sorbifolium husk, 10 parts of mint, 20 parts of mulberry branch, 20 parts of salvia miltiorrhiza, 10 parts of lotus leaf, 5 parts of Chuanxiong, 8 parts of Gentiana, scorpion 15 parts, 7 parts of burdock seed, 10 parts of kudzu root, 10 parts of licorice.

[0034] Preparation method: Take the medicinal materials of the above weight components, add water 5 times the total weight of the medicinal materials, soak for 30 minutes, decoct twice for 2 hours each time, filter, combine the filtrates, and concentrate the filtrates under reduced pressure to a relative density of 1.1 The extractant, the relative density is the test result at 60 degrees Celsius, add ethanol until the alcohol content is 75% (v / v), let it stand for 24 hours, take the supernatant, recover the ethano...

Embodiment 2

[0035] Embodiment 2 Chinese medicine composition tablet of the present invention

[0036] Prescription: 15 parts of Scutellaria baicalensis, 6 parts of honeysuckle, 10 parts of pomegranate peel, 10 parts of radix sorbifolium husk, 10 parts of mint, 20 parts of mulberry branch, 20 parts of salvia miltiorrhiza, 10 parts of lotus leaf, 5 parts of Chuanxiong, 8 parts of Gentiana, scorpion 15 parts, 7 parts of burdock seed, 10 parts of kudzu root, 10 parts of licorice.

[0037] Preparation method: Take each medicinal material of the above weight components, add water 10 times the total weight of the medicinal materials, soak for 60 minutes, decoct once, 1 hour each time, filter, combine the filtrate, and concentrate the filtrate under reduced pressure to a relative density of 1.25 The extract, the relative density is the test result at 60 degrees Celsius, add ethanol to the alcohol content of 80% (v / v), let it stand for 24 hours, take the supernatant, recover the ethanol until conc...

Embodiment 3

[0038] Embodiment 3 Chinese medicine composition capsule of the present invention

[0039] Prescription: 15 parts of Scutellaria baicalensis, 6 parts of honeysuckle, 10 parts of pomegranate peel, 10 parts of radix sorbifolium husk, 10 parts of mint, 20 parts of mulberry branch, 20 parts of salvia miltiorrhiza, 10 parts of lotus leaf, 5 parts of Chuanxiong, 8 parts of Gentiana, scorpion 15 parts, 7 parts of burdock seed, 10 parts of kudzu root, 10 parts of licorice.

[0040] Preparation method: Take the medicinal materials of the above weight components, add water 8 times the total weight of the medicinal materials, soak for 45 minutes, decoct 4 times for 1.5 hours each time, filter, combine the filtrate, and concentrate the filtrate under reduced pressure to a relative density of 1.2 The extract, the relative density is the test result at 60 degrees Celsius, add ethanol to the alcohol content of 90% (v / v), let it stand for 24 hours, take the supernatant, recover the ethanol to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine composition for treating an ischemic cerebrovascular disease and application thereof in preparation of a medicament for preventing or treating the ischemic cerebrovascular disease, and belongs to the technical field of medicines. Aiming at the problem that a chemotherapeutic medicament for the ischemic cerebrovascular disease at present is large in hepatotoxicity, the traditional Chinese medicine composition for treating the ischemic cerebrovascular disease provided by the invention comprises the following components in parts by weight: 15 parts of scutellaria baicalensis, 6 parts of honeysuckle, 10 parts of pomegranate bark, 10 parts of shiny-leaved yellowhorn shell, 10 parts of mint, 20 parts of ramulus mori, 20 parts of root of red-rooted salvia, 10 parts of lotus leaves, 5 parts of ligusticum wallichii, 8 parts of large-leaved gentian, 15 parts of scorpio, 7 parts of burdock, 10 parts of root of kudzu vine and 10 parts of liquorice. The traditional Chinese medicine composition has a good treatment effect in the aspect of treatment of the ischemic cerebrovascular disease, and has significant clinical popularization value.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating ischemic cerebrovascular disease, belonging to the technical field of medicine. Background technique [0002] Ischemic cerebrovascular disease (ICVD) accounts for about 80% of all cerebrovascular diseases. It has the characteristics of high incidence, high disability rate and high cure rate, and has become one of the diseases that seriously endanger human health. Ischemic cerebrovascular disease is one of the most important diseases in cerebrovascular diseases. It is a sudden imbalance between the supply and demand of oxygen and other nutrients provided by the local blood circulation and the metabolic needs of neurons, which eventually leads to the central area of ​​ischemia. A class of diseases in which neurons are damaged. Transient ischemic attack referred to as TIA, also known as transient ischemic attack or small stroke, it is due to the short-term insufficient blood...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/77A61P9/10A61K35/646
Inventor 寇红梅
Owner 启东市丰武农副产品专业合作社
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap